Cor Vasa 2012, 54(1-2):e22-e26 | DOI: 10.1016/j.crvasa.2012.01.006

Proteomic analysis of the plasma samples of patients with stable angina pectoris

Martin Malýa, Pavel Májekb, Zuzana Reicheltováb, Jiří Suttnarb, Roman Kotlínb, Petr Hájeka, Milan Oraveca, Jan E. Dyrb, Josef Veselkaa
a Kardiologická klinika, 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Motol, Praha, Česká republika
b Ústav hematologie a krevní transfuze, Praha, Česká republika

Keywords: Angina pectoris; Mass spectrometry; Proteomic analysis

Received: December 17, 2011; Revised: January 14, 2012; Accepted: January 20, 2012; Published: January 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Malý M, Májek P, Reicheltová Z, Suttnar J, Kotlín R, Hájek P, et al.. Proteomic analysis of the plasma samples of patients with stable angina pectoris. Cor Vasa. 2012;54(1-2):e22-26. doi: 10.1016/j.crvasa.2012.01.006.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Miller DT, Ridker PM, Libby P, Kwiatowski DJ. Atheroslerosis - the path from genomics to therapeutics. J Am Coll Cardiol 2007;49:1589-99. Go to original source... Go to PubMed...
    2. Bijnens AP, Lutgens E, Ayoubi T, Kuiper J, Horrevoets AJ, Daemen MJ. Genome-wide expression studies of atherosclerosis: critical issues in methodology, analysis, interpretation of transcriptomics data. Arterioscler Thromb Vasc Biol 2006;26:1226-35. Go to original source... Go to PubMed...
    3. Tuomisto TT, Binder BR, Yla-Herttuala S. Genetics, genomics and proteomics in atherosclerosis research. Ann Med 2005;37:323-32. Go to original source... Go to PubMed...
    4. Májek P, Reicheltova Z, Stikarová J, Suttnar J, Sobotková A, Dyr JE. Proteome changes in platelets activated by arachidonic acid, collagen and thrombin. Proteome Sci 2010;8:56. Go to original source... Go to PubMed...
    5. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304-51. Go to original source... Go to PubMed...
    6. Tuñón J, Martín-Ventura JL, Blanco-Colio LM, Lorenzo O, López JA, Egido J. Proteomic strategies in the search of new biomarkers in atherothrombosis. J Am Coll Cardiol 2010;55:2009-16. Go to original source... Go to PubMed...
    7. De Kleijn, Moll FL, Hellings WE, et al. Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events. Arterioscler Thromb Vasc Biol 2010;30:612-9. Go to original source... Go to PubMed...
    8. Barderas MG, Tuñón J, Dardé VM, et al. Circulating human monocytes in the acute coronary syndrome express a characteristic proteomic profile. J Proteome Res 2007;6:876-86. Go to original source... Go to PubMed...
    9. Anderson L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol 2005;563:23-60. Go to original source... Go to PubMed...
    10. Ping P, Vondriska TM, Creighton CJ, et al. A functional annotation of subproteomes in human plasma. Proteomics 2005;5:3506-19. Go to original source... Go to PubMed...
    11. Brea D, Sobrino T, Blanco M, et al. Usefulness of haltoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis confirmation. Atherosclerosis 2009;205:561-7. Go to original source... Go to PubMed...
    12. Mateos-Cáceres PJ, García-Méndez A, López Farré A, et al. Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 2004;44:1578-83. Go to original source... Go to PubMed...
    13. Ikonomidis I, Lekakis J, Revela I, Andreotti F, Nihoyannopoulos P. Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery disease. Eur Heart J 2005;26:1618-24. Go to original source... Go to PubMed...
    14. Foussas SG, Zairis MN, Lyras AG, et al. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes. Am J Cardiol 2005;96:533-7. Go to original source... Go to PubMed...
    15. Kosuge M, Ebina T, Ishikawa T, et al. Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes. Circ J 2007;71:186-90. Go to original source... Go to PubMed...
    16. Svensson AM, Whiteley GR, Callas PW, Bovill EG. SELDI-TOF plasma profiles distinguish individuals in a protein C-deficient family with thrombotic episodes occuring before age 40. Thromb Haemost 2006;96:725-30. Go to original source... Go to PubMed...
    17. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417-24. Go to original source... Go to PubMed...
    18. Shi Y, Wu Y, Bian C, Zhang W, Yang J, Xu G. Predictive value of plasma fibrinogen levels in patients admitted for acute coronary syndrome. Tex Heart Inst J 2010;37:178-83.
    19. Riedel T, Suttnar J, Brynda E, Houska M, Medved L, Dyr JE. Fibrinopeptides A and B release in the process of surface fibrin formation. Blood 2011;117:1700-6. Go to original source... Go to PubMed...
    20. Smith JD. Apoliprotein A-1 and its mimetics for the treatment of atherosclerosis. Curr Opin Investig Drugs 2010;11:989-96. Go to PubMed...
    21. Heinecke JW. The HDL-proteome: a marker and perhaps a mediator of coronary artery disease. J Lipid Res 2009;50(S):167-71. Go to original source... Go to PubMed...
    22. Tahara N, Yamagishi SI, Tahara A, et al. Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humus. Atherosclerosis 2011;219:311-5. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes